EKOS™ Endovascular System

HI-PEITHO video series

The Results are Clear. Intervene with EKOS

HI-PEITHO Unpacked

In this 5-part video series, we explore the components of HI-PEITHO, the first large-scale global randomized controlled trial (N=544) powered to determine whether ultrasound-facilitated, catheter-directed thrombolysis (USCDT) via the EKOS Endovascular System plus anticoagulation (AC) improves outcomes versus anticoagulation alone in acute intermediate-risk pulmonary embolism (PE).

HI-PEITHO: Overview

Start with a concise overview of the HI-PEITHO Trial and hear leading experts introduce the rationale, clinical questions, and importance of the study.

Hear from the physicians

HI-PEITHO: Trial Design

Watch as Dr. Peter Monteleone explains why the HI-PEITHO Trial was needed and what randomized evidence means for patient care.

Hear from the physicians

HI-PEITHO: Results

Listen to Prof. Stavros Konstantinides explain the clinical rationale, patient selection, and the primary trial results.

Hear from the physicians

HI-PEITHO: EKOS Technology

Dr. Michael Young discusses the technology behind EKOS and what the HI-PEITHO results could mean for the future of PE care.

Hear from the physicians

HI-PEITHO: Putting Evidence into Practice

Watch as Dr. Soophia Naydenov explains risk stratification, the NEWS score, and applying clinical evidence to critical decision making when treating PE patients.

Hear from the physicians

Stay up to date

Receive emails on the latest advances, EKOS clinical data and news.

My account

HI-PEITHO video series

On this page

HI-PEITHO Unpacked

HI-PEITHO: Overview

HI-PEITHO: Trial Design

HI-PEITHO: Results

HI-PEITHO: EKOS Technology

HI-PEITHO: Putting Evidence into Practice

Stay up to date